| 2.12 Delayed Data As of Jul 19 |  -0.09 / -4.07%Today’s Change | 1.88 Today|||52-Week Range 7.57 | -24.82% Year-to-Date |
| The 6 Best Marijuana Stocks in June Jul 08 / MotleyFool.com - Paid Partner Content | U.S. Marijuana Sales Should More Than Double to $22 Billion by 2022 Jul 07 / MotleyFool.com - Paid Partner Content |
| Previous close | 2.21 |
| Today’s open | 2.20 |
| Day’s range | 2.11 - 2.23 |
| Volume | 776,592 |
| Average volume (3 months) | 1,175,682 |
| Market cap | $1.1B |
| Earnings growth (last year) | -675.14% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +2,067,803.02% |
| P/E ratio | -- |
| Price/Sales | 0.97 |
| Price/Book | 0.93 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $39.8M |
| Annual profit (last year) | -$66.6M |
| Net profit margin | -167.53% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Adam Bierman |
President & Director Andrew Modlin |
Corporate headquarters Culver City, California |
